Eton Pharmaceuticals, Inc. (ETON)
64.43
+0.96
(+1.51%)
USD |
NASDAQ |
Aug 24, 16:00
65.55
+1.12
(+1.74%)
Pre-Market: 08:42
Eton Pharmaceuticals Market Cap : 1.823B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.823B |
| August 21, 2026 | 1.796B |
| August 20, 2026 | 1.695B |
| August 19, 2026 | 1.739B |
| August 18, 2026 | 1.794B |
| August 17, 2026 | 1.746B |
| August 14, 2026 | 1.665B |
| August 13, 2026 | 1.154B |
| August 12, 2026 | 1.176B |
| August 11, 2026 | 1.190B |
| August 10, 2026 | 1.195B |
| August 07, 2026 | 1.220B |
| August 06, 2026 | 1.263B |
| August 05, 2026 | 1.258B |
| August 04, 2026 | 1.254B |
| August 03, 2026 | 1.235B |
| July 31, 2026 | 1.270B |
| July 30, 2026 | 1.341B |
| July 29, 2026 | 1.317B |
| July 28, 2026 | 1.277B |
| July 27, 2026 | 1.158B |
| July 24, 2026 | 1.165B |
| July 23, 2026 | 1.208B |
| July 22, 2026 | 1.192B |
| July 21, 2026 | 1.182B |
| Date | Value |
|---|---|
| July 20, 2026 | 1.124B |
| July 17, 2026 | 1.158B |
| July 16, 2026 | 1.018B |
| July 15, 2026 | 1.053B |
| July 14, 2026 | 1.026B |
| July 13, 2026 | 1.022B |
| July 10, 2026 | 1.002B |
| July 09, 2026 | 1.021B |
| July 08, 2026 | 989.60M |
| July 07, 2026 | 1.033B |
| July 06, 2026 | 1.040B |
| July 02, 2026 | 1.026B |
| July 01, 2026 | 1.002B |
| June 30, 2026 | 990.42M |
| June 29, 2026 | 1.005B |
| June 26, 2026 | 976.74M |
| June 25, 2026 | 952.67M |
| June 24, 2026 | 929.69M |
| June 23, 2026 | 916.28M |
| June 22, 2026 | 895.21M |
| June 18, 2026 | 888.65M |
| June 17, 2026 | 896.31M |
| June 16, 2026 | 885.09M |
| June 15, 2026 | 879.62M |
| June 12, 2026 | 864.30M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nektar Therapeutics | 2.515B |
| Pfizer Inc. | 159.40B |
| Elite Pharmaceuticals, Inc. | 311.40M |
| Daré Bioscience, Inc. | 12.16M |
| Liquidia Corp. | 6.261B |
Market Cap Related Metrics
| PE Ratio | 170.31 |
| PS Ratio | 18.68 |
| Price to Book Value | 39.13 |
| Price | 64.43 |
| Earnings Yield | 0.59% |
| Operating PE Ratio | 119.51 |
| Normalized PE Ratio | 168.09 |